M&Amp;A | Global Growth Markets

Cardinal Health sells China operations for USD557 mn

Insights

21-Nov-17 Shanghai Pharmaceuticals has agreed to pay USD557 million for Cardinal Health’s China drug distribution business, growing its nationwide presence and making it a distributor to 322 cities and 11,000 medical institutions. [image: Healthcare Packaging]

Fortis board clears RHT acquisition in India

Insights

15-Nov-17 Fortis Healthcare board has approved the proposed acquisition of Singapore based RHT Health Trust for INR4,650 crore (USD720 mn), as part of an effort to consolidate the Indian asset portfolio of clinical establishments and two hospitals into Fortis. [image: ET Healthworld]

Fosun Pharma acquires 74% stake in Gland Pharma for USD1.1 bn

05-Oct-17 Chinese drug firm Fosun Pharma has acquired a 74% controlling interest of Hyderabad based Gland Pharma at a valuation of USD1.1 bn. The new owners intend to keep present management in charge of the day-to-day running of the company. [image: Gland Pharma Limited]

India's Star Health Insurance starts sale plan with USD1 bn price tag

04-Oct-17 The largest independent health insurance company in India, Chennai based Star Health & Allied Insurance, has formally kicked off a sale process with an asking price of USD900 mn to USD1 bn. [image: ET Healthworld]

Air Liquide announces a healthcare acquisition in Japan

26-Sep-17 Air Liquide is expanding its healthcare business in Japan with the acquisition of Sogo Sangyo Kabushiki Kaisha, a Japanese player with a strong presence in the home healthcare and medical gases markets, especially in the Tokyo region. [image: Air Liquide]

M&a

Cardinal Health sells China operations for USD557 mn

Fortis board clears RHT acquisition in India

Fosun Pharma acquires 74% stake in Gland Pharma for USD1.1 bn

India's Star Health Insurance starts sale plan with USD1 bn price tag

Air Liquide announces a healthcare acquisition in Japan

Share

Latest

About us

Why Global Growth Markets?

Contact